Treatment using either the thiol isomerase inhibitor isoquercetin or zafirlukast lowers tissue factor levels, decreases VEGF, inhibits PD‐L1, and TMEM176B in a xenograft model of ovarian cancer. A combination of the two agents, at threefold lower concentrations than either drug, significantly enhanced the inhibition further, suggesting a dual action of
Justine A. Keovilay +4 more
wiley +1 more source
An Evaluation of Osseointegration Outcomes Around Trabecular Metal Implants in Human Maxillaries Reconstructed with Allograft and Platelet-Rich Fibrin. [PDF]
Oroumieh SI +9 more
europepmc +1 more source
Tooth Graft and Platelet-Rich Fibrin Mixture for Oral Bone Reconstruction and Preservation: A Scoping Review. [PDF]
Shekarian M +5 more
europepmc +1 more source
Efficacy of Injectable Platelet-Rich Fibrin for Interdental Papilla Reconstruction Compared With Connective Tissue Grafts: A Randomized Controlled Clinical Trial. [PDF]
Johnson J +6 more
europepmc +1 more source
Efficacy of leukocyte- and platelet-rich fibrin in the treatment and prevention of medication-related osteonecrosis of the jaw: a prospective study. [PDF]
Medeiros-Monzón A +6 more
europepmc +1 more source
The Evolution of Extended Platelet-Rich Fibrin Membranes for Socket Grafting: Part Two: A Randomized Clinical Trial Comparing These Membranes with Collagen Membranes. [PDF]
Estrin NE +7 more
europepmc +1 more source
Application of Platelet-Rich Fibrin and Concentrated Growth Factors as Carriers for Antifungal Drugs-In Vitro Study. [PDF]
Niemczyk W +5 more
europepmc +1 more source
Platelet-Rich Plasma and Platelet-Rich Fibrin in Endodontics: A Scoping Review. [PDF]
Rebimbas Guerreiro S +6 more
europepmc +1 more source
Comparative efficacy of autologous platelet-rich fibrin and collagen membrane on clinical outcomes following vestibuloplasty: A randomized controlled trial. [PDF]
Sharma U +5 more
europepmc +1 more source

